[
  {
    "ts": null,
    "headline": "How Evolving Analyst Assumptions Are Reshaping The Story For Vertex Pharmaceuticals (VRTX)",
    "summary": "Vertex Pharmaceuticals has just seen its price target move from a previously unspecified level to a new, undisclosed figure. This signals a refreshed view of the stock’s potential by covering analysts. The shift reflects updated expectations embedded in recent commentary around the company, even though the exact drivers of that change are not detailed here. Stay with this article to see how you can keep track of future price target moves and the evolving narrative around Vertex. Stay updated...",
    "url": "https://finnhub.io/api/news?id=a763480f0d889f2563ec95cc12df49707dc0ffdf21ddd440788004b34263d75c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769263559,
      "headline": "How Evolving Analyst Assumptions Are Reshaping The Story For Vertex Pharmaceuticals (VRTX)",
      "id": 138245894,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals has just seen its price target move from a previously unspecified level to a new, undisclosed figure. This signals a refreshed view of the stock’s potential by covering analysts. The shift reflects updated expectations embedded in recent commentary around the company, even though the exact drivers of that change are not detailed here. Stay with this article to see how you can keep track of future price target moves and the evolving narrative around Vertex. Stay updated...",
      "url": "https://finnhub.io/api/news?id=a763480f0d889f2563ec95cc12df49707dc0ffdf21ddd440788004b34263d75c"
    }
  }
]